These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 12028244)
1. Tacrine therapy is associated with reduced mortality in nursing home residents with dementia. Ott BR; Lapane KL J Am Geriatr Soc; 2002 Jan; 50(1):35-40. PubMed ID: 12028244 [TBL] [Abstract][Full Text] [Related]
2. Is donepezil therapy associated with reduced mortality in nursing home residents with dementia? Gasper MC; Ott BR; Lapane KL Am J Geriatr Pharmacother; 2005 Mar; 3(1):1-7. PubMed ID: 16089241 [TBL] [Abstract][Full Text] [Related]
3. Tacrine use in nursing homes: implications for prescribing new cholinesterase inhibitors. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology. Gifford DR; Lapane KL; Gambassi G; Landi F; Mor V; Bernabei R Neurology; 1999 Jan; 52(2):238-44. PubMed ID: 9932937 [TBL] [Abstract][Full Text] [Related]
4. All-cause mortality associated with atypical and conventional antipsychotics among nursing home residents with dementia: a retrospective cohort study. Liperoti R; Onder G; Landi F; Lapane KL; Mor V; Bernabei R; Gambassi G J Clin Psychiatry; 2009 Oct; 70(10):1340-7. PubMed ID: 19906339 [TBL] [Abstract][Full Text] [Related]
5. Statin discontinuation in nursing home residents with advanced dementia. Tjia J; Cutrona SL; Peterson D; Reed G; Andrade SE; Mitchell SL J Am Geriatr Soc; 2014 Nov; 62(11):2095-101. PubMed ID: 25369872 [TBL] [Abstract][Full Text] [Related]
6. Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementia. Daiello LA; Ott BR; Lapane KL; Reinert SE; Machan JT; Dore DD Am J Geriatr Pharmacother; 2009 Apr; 7(2):74-83. PubMed ID: 19447360 [TBL] [Abstract][Full Text] [Related]
7. Cholinesterase inhibitors and memantine are associated with a reduced mortality in nursing home residents with dementia: a longitudinal observational study. Havreng-Théry C; Oquendo B; Zolnowski-Kolp V; Krolak-Salmon P; Bertin-Hugault F; Lafuente-Lafuente C; Belmin J Alzheimers Res Ther; 2024 May; 16(1):117. PubMed ID: 38812028 [TBL] [Abstract][Full Text] [Related]
8. Five-year outcome of cholinergic treatment of Alzheimer's disease: early response predicts prolonged time until nursing home placement, but does not alter life expectancy. Wallin AK; Gustafson L; Sjögren M; Wattmo C; Minthon L Dement Geriatr Cogn Disord; 2004; 18(2):197-206. PubMed ID: 15211076 [TBL] [Abstract][Full Text] [Related]
9. Factors Associated with Mortality Including Nursing Home Transitions: A Retrospective Analysis of 25,418 People Prescribed Anti-Dementia Drugs in Northern Ireland. McMichael AJ; Zafeiridi E; Passmore P; Cunningham EL; McGuinness B J Alzheimers Dis; 2020; 73(3):1233-1242. PubMed ID: 31903992 [TBL] [Abstract][Full Text] [Related]
10. Cholinesterase inhibitor use in U.S. nursing homes: results from the national nursing home survey. Seitz DP; Gruneir A; Conn DK; Rochon PA J Am Geriatr Soc; 2009 Dec; 57(12):2269-74. PubMed ID: 19874411 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of tacrine in nursing home residents with Alzheimer's dementia. Woo JK; Lantz MS; Marchello V; Libow LS J Am Geriatr Soc; 1996 Nov; 44(11):1411-2. PubMed ID: 8909368 [No Abstract] [Full Text] [Related]
12. The use of survival analysis techniques in evaluating the effect of long-term tacrine (Cognex) treatment on nursing home placement and mortality in patients with Alzheimer's disease. Smith F; Talwalker S; Gracon S; Srirama M J Biopharm Stat; 1996 Nov; 6(4):395-409. PubMed ID: 8969976 [TBL] [Abstract][Full Text] [Related]
13. Estimating prognosis for nursing home residents with advanced dementia. Mitchell SL; Kiely DK; Hamel MB; Park PS; Morris JN; Fries BE JAMA; 2004 Jun; 291(22):2734-40. PubMed ID: 15187055 [TBL] [Abstract][Full Text] [Related]
14. Cholinesterase inhibitor and memantine use in newly admitted nursing home residents with dementia. Parsons C; Briesacher BA; Givens JL; Chen Y; Tjia J J Am Geriatr Soc; 2011 Jul; 59(7):1253-9. PubMed ID: 21668913 [TBL] [Abstract][Full Text] [Related]
15. Antipsychotic drug use among nursing home residents taking rivastigmine. Narayanan S; Beusterien KM; Thomas SK; Musher J; Strunk B J Am Med Dir Assoc; 2006 Jan; 7(1):12-6. PubMed ID: 16413429 [TBL] [Abstract][Full Text] [Related]
16. Mortality and adverse health events in newly admitted nursing home residents with and without dementia. Magaziner J; Zimmerman S; Gruber-Baldini AL; van Doorn C; Hebel JR; German P; Burton L; Taler G; May C; Quinn CC; Port CL; Baumgarten M; J Am Geriatr Soc; 2005 Nov; 53(11):1858-66. PubMed ID: 16274365 [TBL] [Abstract][Full Text] [Related]
17. Predictors of mortality in nursing home residents with advanced dementia. Hicks KL; Rabins PV; Black BS Am J Alzheimers Dis Other Demen; 2010 Aug; 25(5):439-45. PubMed ID: 20601644 [TBL] [Abstract][Full Text] [Related]
18. Use of drugs with anticholinergic properties among nursing home residents with dementia: a national analysis of Medicare beneficiaries from 2007 to 2008. Palmer JB; Albrecht JS; Park Y; Dutcher S; Rattinger GB; Simoni-Wastila L; Walker LD; Zuckerman IH Drugs Aging; 2015 Jan; 32(1):79-86. PubMed ID: 25491558 [TBL] [Abstract][Full Text] [Related]
19. Gender differences in the relation between comorbidity and mortality of patients with Alzheimer's disease. Systematic Assessment of Geriatric drug use via Epidemiology (SAGE) Study Group. Gambassi G; Lapane KL; Landi F; Sgadari A; Mor V; Bernabie R Neurology; 1999 Aug; 53(3):508-16. PubMed ID: 10449112 [TBL] [Abstract][Full Text] [Related]
20. Predictors of mortality in patients with Alzheimer's disease living in nursing homes. Gambassi G; Landi F; Lapane KL; Sgadari A; Mor V; Bernabei R J Neurol Neurosurg Psychiatry; 1999 Jul; 67(1):59-65. PubMed ID: 10369823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]